The Week Ahead In Biotech: Focus On Epizyme, Merck Ahead Of PDUFA Dates, J&J To Kickstart Big Pharma Earnings
Biotech news flow remained light last week, although there were some notable developments such as FDA panel reviews…
A Look at Some ‘Legit’ OTC Stocks
Many investors are leery of OTC, or over-the-counter, stocks – and there are plenty of good reasons for that caution. OTC stocks often involve companies too small to be listed and traded on the coventional and better-known stock exchanges.